Patent · US Active

Therapeutic agents for the treatment of HBV infection

US10239872B2 · kind B2 · utility

3Cited by
1References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 14, 2018
Grant dateMar 26, 2019
Priority date—
Expiry dateFeb 14, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The disclosure includes compounds of Formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.